Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)

CUSIP: 14161Y200

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Class A Common Shares
Shares outstanding
117,125,812
Total 13F shares
7,493,301
Share change
+2,510,232
Total reported value
$9,599,808
Put/Call ratio
78%
Price per share
$1.28
Number of holders
43
Value change
+$3,011,551
Number of buys
21
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 14161Y200?
CUSIP 14161Y200 identifies CRDL - Cardiol Therapeutics Inc. - Class A Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q4 2024

As of 31 Dec 2024, Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,493,301 shares. The largest 10 holders included Tejara Capital Ltd, AdvisorShares Investments LLC, MMCAP International Inc. SPC, PVG ASSET MANAGEMENT CORP, Cambridge Investment Research Advisors, Inc., ENVESTNET ASSET MANAGEMENT INC, Lion Street Advisors, LLC, UBS Group AG, MORGAN STANLEY, and Atria Investments, Inc. This page lists 43 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.